BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9581851)

  • 1. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
    Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
    Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway.
    Langley B; Thomas M; McFarlane C; Gilmour S; Sharma M; Kambadur R
    Oncogene; 2004 Jan; 23(2):524-34. PubMed ID: 14724580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL; McLean TI; Bachenheimer SL
    Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.
    Matsuo T; Thiele CJ
    Oncogene; 1998 Jun; 16(25):3337-43. PubMed ID: 9681834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
    Sirri V; Leibovitch MP; Leibovitch SA
    Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
    Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
    Wasserman LM; Newsham I; Huang HJ; Cavenee WK
    Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of myogenic differentiation program in cultured normal postmitotic mononucleated myoblasts and the aberrant differentiation in rhabdomyosarcoma cells].
    Lin ZX; Zhang ZQ; Han YL; Zhou LX; Mei HL; Holtzer H
    Shi Yan Sheng Wu Xue Bao; 1994 Mar; 27(1):79-89. PubMed ID: 8042410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
    Crouch GD; Kalebic T; Tsokos M; Helman LJ
    Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maduramicin inhibits proliferation and induces apoptosis in myoblast cells.
    Chen X; Gu Y; Singh K; Shang C; Barzegar M; Jiang S; Huang S
    PLoS One; 2014; 9(12):e115652. PubMed ID: 25531367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.
    Rosenthal SM; Cheng ZQ
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10307-11. PubMed ID: 7479773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.
    Skapek SX; Rhee J; Spicer DB; Lassar AB
    Science; 1995 Feb; 267(5200):1022-4. PubMed ID: 7863328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation.
    Cenciarelli C; De Santa F; Puri PL; Mattei E; Ricci L; Bucci F; Felsani A; Caruso M
    Mol Cell Biol; 1999 Jul; 19(7):5203-17. PubMed ID: 10373569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.
    Shapiro DN; Houghton PJ; Hazelton BJ; Germain GS; Murti KG; Rahman A; Houghton JA
    Cancer Res; 1990 Sep; 50(18):6002-9. PubMed ID: 2203524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
    Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
    Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.